| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in IONS over the last quarter tilts toward selling: insiders offloaded a net 1,410 shares worth roughly $61K. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 242.8K | $9.71M | - | |
| Dir | 161.2K | $6.45M | - | |
| VP | 102.9K | $4.11M | - | |
| CFO | 82.7K | $3.31M | - | |
| VP | 77.1K | $3.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2024 | Onaiza Cadoret-Manier53 | EVP, Chf Gl Pdt Str & Oper Ofc | Sale+OE | 5,564 | $50.42 | $280,520.19 | -14.1% | -19.0% | -37.1% | |
| Jan 12, 2024 | Eugene Schneider63 | EVP, Chf Clinical Develop Officer | Sale+OE10b5-1 | 8,000 | $53.50 | $427,999.20 | -17.3% | -20.6% | -37.5% | |
| Dec 28, 2023 | Eric Swayze67 | EVP Research | Sale+OE10b5-1 | 27,100 | $50.19 | $1,360,081.25 | -45.5% | -11.6% | -28.9% | |
| Dec 28, 2023 | B Lynne Parshall72 | Director | Sale+OE10b5-1 | 117,638 | $50.48 | $5,938,128.76 | -58.8% | -11.6% | -28.9% | |
| Dec 26, 2023 | Eugene Schneider63 | EVP, Chf Clinical Develop Officer | Sale+OE10b5-1 | 25,000 | $51.46 | $1,286,575.00 | -40.9% | -14.4% | -29.2% | |
| Dec 26, 2023 | Patrick R. O'Neil63 | EVP CLO & General Counsel | Sale+OE10b5-1 | 20,825 | $51.46 | $1,071,716.98 | -34.0% | -14.4% | -29.2% | |
| Dec 21, 2023 | Brett P Monia63 | Chief Executive Officer | Sale+OE10b5-1 | 24,000 | $49.38 | $1,185,219.85 | -16.9% | -12.9% | -27.4% | |
| Dec 21, 2023 | Richard S Geary66 | EVP, Chief Development Officer | Sale+OE10b5-1 | 10,612 | $49.50 | $525,323.99 | -12.7% | -12.9% | -27.4% | |
| Dec 21, 2023 | C Frank Bennett64 | EVP, Chief Scientific Officer | Sale+OE10b5-1 | 22,613 | $49.39 | $1,116,854.48 | -25.6% | -12.9% | -27.4% | |
| Dec 14, 2023 | C Frank Bennett64 | EVP, Chief Scientific Officer | Sale+OE10b5-1 | 22,612 | $49.58 | $1,121,194.70 | -25.6% | -13.4% | -26.5% |